Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A - TCF7L2 fusion von Getz, Gad, Meyerson, Matthew, Bass, Adam J, Lawrence, Michael S, Brace, Lear E, Ramos, Alex H, Drier, Yotam, Cibulskis, Kristian, Sougnez, Carrie, Voet, Douglas, Saksena, Gordon, Sivachenko, Andrey, Jing, Rui, Parkin, Melissa, Pugh, Trevor, Verhaak, Roel G, Stransky, Nicolas, Boutin, Adam T, Barretina, Jordi, Solit, David B, Vakiani, Evi, Shao, Wenlin, Mishina, Yuji, Warmuth, Markus, Jimenez, Jose, Chiang, Derek Y, Signoretti, Sabina, Kaelin, William G, Spardy, Nicole, Hahn, William C, Hoshida, Yujin, Ogino, Shuji, DePinho, Ronald A, Chin, Lynda, Garraway, Levi A, Fuchs, Charles S, Baselga, Jose, Tabernero, Josep, Gabriel, Stacey, Lander, Eric S

Volltext

P-517 A phase II study of irinotecan, cisplatin, and mitomycin C (IPM) in malignant pleural mesothelioma von Fennell, Dean A., Steele, Jeremy P.C., Shamash, Jonathan, Evans, Marie T., Wells, Paula, Sheaff, Michael T., Gower, Nicole H., Vakiani, Evi, Barlow, Claire, Rudd, Robin M.

Volltext

Genomic sequencing of colorectal adenocarcinomas identifies a recurrent YTI1A-TCF7L2 fusion von BASS, Adam J, LAWRENCE, Michael S, RUI JING, PARKIN, Melissa, PUGH, Trevor, VERHAAK, Roel G, STRANSKY, Nicolas, BOUTIN, Adam T, BARRETINA, Jordi, SOLIT, David B, VAKIANI, Evi, SHAO, Wenlin, BRACE, Lear E, MISHINA, Yuji, WARMUTH, Markus, JIMENEZ, Jose, CHIANG, Derek Y, SIGNORETTI, Sabina, KAELIN, William G, SPARDY, Nicole, HAHN, William C, HOSHIDA, Yujin, OGINO, Shuji, RAMOS, Alex H, DEPINHO, Ronald A, CHIN, Lynda, GARRAWAY, Levi A, FUCHS, Charles S, BASELGA, Jose, TABERNERO, Josep, GABRIEL, Stacey, LANDER, Eric S, GETZ, Gad, MEYERSON, Matthew, DRIER, Yotam, CIBULSKIS, Kristian, SOUGNEZ, Carrie, VOET, Douglas, SAKSENA, Gordon, SIVACHENKO, Andrey

Volltext

Sirolimus-associated hepatotoxicity: case report and review of the literature von Macdonald, Brock, Vakiani, Evi, Yantiss, Rhonda K, Lee, Jun, Brown, Jr., Robert S, Sigal, Samuel H

Volltext

P-518 Second line therapy of malignant pleural mesothelioma with irinotecan, cisplatin, and mitomycin C (IPM): A phase II study von Fennell, Dean A., Steele, Jeremy P.C., Shamash, Jonathan, Evans, Marie T., Sheaff, Michael T., Wells, Paula, Vakiani, Evi, Gower, Nicole H., Barlow, Claire, Rudd, Robin M.

Volltext